85. Idiopathic interstitial pneumonia Clinical trials / Disease details

Clinical trials : 598 / Drugs : 435 - (DrugBank : 116) / Drug target genes : 100 - Drug target pathways : 210

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00981747 (ClinicalTrials.gov)	September 2009	19/9/2009	Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis	A Clinical Treatment Trial Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis	Idiopathic Pulmonary Fibrosis;Pulmonary Fibrosis	Drug: Sildenafil;Drug: Losartan;Drug: Sildenafil and Losartan;Drug: Placebo Oral Tablet	Alicia Gerke	Pulmonary Fibrosis Foundation	Terminated	18 Years	99 Years	All	12	Phase 2/Phase 3	United States
2	NCT00879879 (ClinicalTrials.gov)	March 2009	10/4/2009	Losartan in Treating Patients With Idiopathic Pulmonary Fibrosis	Treatment of Idiopathic Pulmonary Fibrosis With Losartan: A Pilot Project	Precancerous Condition	Drug: losartan	University of South Florida	National Cancer Institute (NCI)	Completed	21 Years	N/A	All	20	N/A	United States